BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: D’Aoust J, Battat R, Bessissow T. Management of inflammatory bowel disease with Clostridium difficile infection. World J Gastroenterol 2017; 23(27): 4986-5003 [PMID: 28785153 DOI: 10.3748/wjg.v23.i27.4986] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 17] [Article Influence: 4.8] [Reference Citation Analysis]
Number Citing Articles
1 Davenport L, Chin-Hon J, Chung J, Chen XJ, Schneider J. 6-Mercaptopurine and Macrophage Activation Syndrome Case Report and Review of the Literature. J Pharm Pract 2022;:8971900221081617. [PMID: 35341387 DOI: 10.1177/08971900221081617] [Reference Citation Analysis]
2 Rodríguez C, Romero E, Garrido-Sanchez L, Alcaín-Martínez G, Andrade RJ, Taminiau B, Daube G, García-Fuentes E. MICROBIOTA INSIGHTS IN CLOSTRIDIUM DIFFICILE INFECTION AND INFLAMMATORY BOWEL DISEASE. Gut Microbes 2020;12:1725220. [PMID: 32129694 DOI: 10.1080/19490976.2020.1725220] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
3 Shoaei P, Shojaei H, Jalali M, Khorvash F, Hosseini SM, Ataei B, Vakili B, Ebrahimi F, Tavakoli H, Esfandiari Z, Weese JS. Clostridium difficile isolated from faecal samples in patients with ulcerative colitis. BMC Infect Dis 2019;19:361. [PMID: 31039738 DOI: 10.1186/s12879-019-3965-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
4 Balram B, Battat R, Al-Khoury A, D'Aoust J, Afif W, Bitton A, Lakatos PL, Bessissow T. Risk Factors Associated with Clostridium difficile Infection in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis. J Crohns Colitis 2019;13:27-38. [PMID: 30247650 DOI: 10.1093/ecco-jcc/jjy143] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 7.3] [Reference Citation Analysis]
5 Kosmidou M, Karavasili NT, Saridi M, Skamnelos A, Kavvadias A, Batistatou A, Gartzonika KG, Tsiara S, Katsanos KH, Christodoulou DK. Clostridium Difficile Infection in Patients Impact Suspected Cytomegalovirus Infection in Patients with Inflammatory Bowel Disease. Mater Sociomed 2020;32:41-5. [PMID: 32410890 DOI: 10.5455/msm.2020.32.41-45] [Reference Citation Analysis]
6 Lee KM. [Monitoring Disease Activity: How and When?]. Korean J Gastroenterol 2018;71:69-73. [PMID: 29471603 DOI: 10.4166/kjg.2018.71.2.69] [Reference Citation Analysis]
7 Vitikainen K, Haapamäki J, Färkkilä M, Anttila VJ, Arkkila P. Clostridium difficile infection in patients with inflammatory bowel disease: a case control study. Scand J Gastroenterol 2018;53:947-51. [PMID: 30041549 DOI: 10.1080/00365521.2018.1492012] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
8 Chandrakumar A, Zohni H, El-matary W. Clostridioides difficile Infection in Children With Inflammatory Bowel Disease. Inflammatory Bowel Diseases 2020;26:1700-6. [DOI: 10.1093/ibd/izz285] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
9 Dalal RS, Allegretti JR. Diagnosis and management of Clostridioides difficile infection in patients with inflammatory bowel disease. Curr Opin Gastroenterol 2021;37:336-43. [PMID: 33654015 DOI: 10.1097/MOG.0000000000000739] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Nana T, Moore C, Boyles T, Brink AJ, Cleghorn J, Devenish LM, du Toit B, Fredericks ES, Lekalakala-Mokaba MR, Maluleka C, Rajabally MN, Reubenson G, Shuping L, Swart K, Swe Han KS, Wadula J, Wojno J, Lowman W. South African Society of Clinical Microbiology Clostridioides difficile infection diagnosis, management and infection prevention and control guideline. S Afr J Infect Dis 2020;35:219. [PMID: 34485483 DOI: 10.4102/sajid.v35i1.219] [Reference Citation Analysis]
11 Moens A, Verstockt B, Machiels K, Bossuyt P, Verdonck A, Lagrou K, van Assche G, Vermeire S, Ferrante M. Clostridium difficile infection in inflammatory bowel disease: epidemiology over two decades. European Journal of Gastroenterology & Hepatology 2019;31:668-73. [DOI: 10.1097/meg.0000000000001394] [Cited by in Crossref: 5] [Article Influence: 1.7] [Reference Citation Analysis]
12 Lei X, Wang Y. Predicting Microbe-Disease Association by Learning Graph Representations and Rule-Based Inference on the Heterogeneous Network. Front Microbiol 2020;11:579. [PMID: 32351464 DOI: 10.3389/fmicb.2020.00579] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
13 Le PH, Chiu CT, Yeh PJ, Pan YB, Chiu CH. Clostridium innocuum Infection in Hospitalized Patients with Inflammatory Bowel Disease: A Retrospective Cohort Study. J Infect 2021:S0163-4453(21)00649-6. [PMID: 34963635 DOI: 10.1016/j.jinf.2021.12.031] [Reference Citation Analysis]
14 Oka D, Yamaya N, Kuno T, Asakawa Y, Shiragiku T, Chen L, Xue J, Mamuti A, Ye F, Sun J, Ohguro K, Miyamoto H, Uematsu Y, Inagaki K, Cheng JF, Matsumoto M. In Vitro and In Vivo Antibacterial Activities of a Novel Quinolone Compound, OPS-2071, against Clostridioides difficile. Antimicrob Agents Chemother 2021;65:e01170-20. [PMID: 33495229 DOI: 10.1128/AAC.01170-20] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
15 Tarasiuk A, Eibl G. Nutritional Support and Probiotics as a Potential Treatment of IBD. Curr Drug Targets 2020;21:1417-27. [PMID: 32364071 DOI: 10.2174/1389450121666200504075519] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
16 Aletaha N, Dadvar Z, Salehi B, Ketabi Moghadam P, Niksirat A, Jowkar A, Taslimi R, Allameh SF, Ebrahimi Daryani N. Clinical and Pathological Features of Ulcerative Colitis in Patients with and without Clostridium Difficile Infection; An Observational Study. Middle East J Dig Dis 2019;11:17-23. [PMID: 31049178 DOI: 10.15171/mejdd.2018.123] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
17 Yang X, Kuang L, Chen Z, Wang L. Multi-Similarities Bilinear Matrix Factorization-Based Method for Predicting Human Microbe-Disease Associations. Front Genet 2021;12:754425. [PMID: 34721543 DOI: 10.3389/fgene.2021.754425] [Reference Citation Analysis]
18 Shaffer SR, Nugent Z, Bernstein CN, Walkty A, Singh H. Effect of clinical versus administrative data definitions on the epidemiology of C. difficile among hospitalized individuals with IBD: a population-based cohort study. BMC Gastroenterol 2022;22. [DOI: 10.1186/s12876-022-02223-y] [Reference Citation Analysis]
19 Bolukcu S, Hakyemez IN, Gultepe BS, Okay G, Durdu B, Koc MM, Aslan T. Clostridium difficile infection: Is there a change in the underlying factors? Inflammatory bowel disease and Clostridium difficile. Saudi J Gastroenterol 2019;25:384-9. [PMID: 31793457 DOI: 10.4103/sjg.SJG_44_19] [Reference Citation Analysis]
20 Linares R, Francés R, Gutiérrez A, Juanola O. Bacterial Translocation as Inflammatory Driver in Crohn's Disease. Front Cell Dev Biol 2021;9:703310. [PMID: 34557484 DOI: 10.3389/fcell.2021.703310] [Reference Citation Analysis]
21 Dong L, Xie J, Wang Y, Zuo D. Gut Microbiota and Immune Responses. Adv Exp Med Biol 2020;1238:165-93. [PMID: 32323185 DOI: 10.1007/978-981-15-2385-4_10] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
22 Lam AY, Gutin LS, Nguyen Y, Velayos FS. Management of Recurrent Clostridioides Infection: A Difficile Problem in Inflammatory Bowel Disease Patients. Dig Dis Sci 2020;65:3111-5. [PMID: 32749638 DOI: 10.1007/s10620-020-06521-x] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]